Nielsen H, Johansson L, Rossi M. "Method for the Synthesis of Abrocitinib Impurity 2" [P]. European Patent, EP 3711032 A1, 2017-12-19.
发明人刘建华,林芳,冯建国. "A Process for Preparing High-Purity Abrocitinib Impurity 2" [P]. 中国发明专利, 专利号 CN 111423857 B, 授权公告日 2021-08-08.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of 阿布昔替尼杂质2 in Pharmaceutical Formulations". Environ. Sci. Technol., 2014, 109, (2), 9013-9022.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿布昔替尼杂质2 as an Impurity". Chemosphere, 2023, 568, (11), 7695-7716.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of Abrocitinib Impurity 2 Using HRMS and NMR". Anal. Methods, 2020, 427, (10), 5627-5637.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate 阿布昔替尼杂质2 Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2012, 249, (7), 5991-6000.